Evidence map›Paper›PMID 38249398›Full record

ArticleFrontiers in public health2023

Smartphone sensors for evaluating COVID-19 fear in patients with cancer: a prospective study.

Gabrielė Kasputytė, Gabrielė Jenciūtė, Nerijus Šakinis, Inesa Bunevičienė, Erika Korobeinikova, Domas Vaitiekus, Arturas Inčiūra, Laimonas Jaruševičius, Romas Bunevičius, Ričardas Krikštolaitis and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Navigating the Intersection of Technology and Depression Precision Medicine.Advances in experimental medicine and biology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Gabrielė KasputytėFaculty of Informatics, Vytautas Magnus University, Kaunas, Lithuania.
Gabrielė JenciūtėFaculty of Informatics, Vytautas Magnus University, Kaunas, Lithuania.
Nerijus ŠakinisFaculty of Informatics, Vytautas Magnus University, Kaunas, Lithuania.
Inesa BunevičienėFaculty of Political Science and Diplomacy, Vytautas Magnus University, Kaunas, Lithuania.
Erika KorobeinikovaOncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Domas VaitiekusOncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Arturas InčiūraOncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Laimonas JaruševičiusOncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Romas BunevičiusProIT, Vilnius, Lithuania.
Ričardas KrikštolaitisFaculty of Informatics, Vytautas Magnus University, Kaunas, Lithuania.
Tomas KrilavičiusFaculty of Informatics, Vytautas Magnus University, Kaunas, Lithuania.
Elona JuozaitytėOncology Institute, Lithuanian University of Health Sciences, Kaunas, Lithuania.
Adomas BunevičiusDepartment of Neurology, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, United States.
Vytautas Magnus University · LTLithuanian University of Health Sciences · LTColumbia University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to analyze the association between the behavior of cancer patients, measured using passively and continuously generated data streams from smartphone sensors (as in digital phenotyping), and perceived fear of COVID-19 and COVID-19 vaccination status. Methods: A total of 202 patients with different cancer types and undergoing various treatments completed the COVID-19 Fears Questionnaire for Chronic Medical Conditions, and their vaccination status was evaluated. Patients' behaviors were monitored using a smartphone application that passively and continuously captures high-resolution data from personal smartphone sensors. In all, 107 patients were monitored for at least 2 weeks. The study was conducted between August 2022 and August 2023. Distributions of clinical and demographical parameters between fully vaccinated, partially vaccinated, and unvaccinated patients were compared using the Chi-squared test. The fear of COVID-19 among the groups was compared using the Mann-Whitney and the Kruskal-Wallis criteria. Trajectories of passively generated data were compared as a function of fear of COVID-19 and COVID-19 vaccination status using local polynomial regression. Results: In total, 202 patients were included in the study. Most patients were fully (71%) or partially (13%) vaccinated and 16% of the patients were unvaccinated for COVID-19. Fully vaccinated or unvaccinated patients reported greater fear of COVID-19 than partially vaccinated patients. Fear of COVID-19 was higher in patients being treated with biological therapy. Patients who reported a higher fear of COVID-19 spent more time at home, visited places at shorter distances from home, and visited fewer places of interest (POI). Fully or partially vaccinated patients visited more POI than unvaccinated patients. Local polynomial regression using passively generated smartphone sensor data showed that, although at the beginning of the study, all patients had a similar number of POI, after 1 week, partially vaccinated patients had an increased number of POI, which later remained, on average, around four POI per day. Meanwhile, fully vaccinated or unvaccinated patients had a similar trend of POI and it did not exceed three visits per day during the entire treatment period. Conclusion: The COVID-19 pandemic continues to have an impact on the behavior of cancer patients even after the termination of the global pandemic. A higher perceived fear of COVID-19 was associated with less movement, more time spent at home, less time spent outside of home, and a lower number of visited places. Unvaccinated patients visited fewer places and were moving less overall during a 14-week follow-up as compared to vaccinated patients.

Indexed as

COVID-19NeoplasmsPhobic DisordersCOVID-19 VaccinesFearHumansPandemicsProspective StudiesSmartphoneCOVID-19 VaccinescancerCOVID-19digital phenotypingfearpatients’ behaviorsensors

Identifiers

PMID38249398
PMCPMC10797074
OpenAlexW4390610020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.